Company Filing History:
Years Active: 2015-2016
Title: Ryouhei Katou: Innovator in Hydrolase Protein Development
Introduction
Ryouhei Katou is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of hydrolase proteins. With a total of two patents to his name, Katou's work is paving the way for advancements in therapeutic agents.
Latest Patents
Katou's latest patents focus on a novel hydrolase protein. This invention is designed to enhance the hydrolysis of dialkyl 2-vinylcyclopropane-1,1-dicarboxylate using an enzyme. The goal is to efficiently produce (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid, which serves as an important intermediate for synthesizing therapeutic agents for hepatitis C. The hydrolase protein consists of specific amino acid sequences that exhibit higher selectivity in catalyzing the desired reaction compared to previous proteins.
Career Highlights
Ryouhei Katou is currently associated with Api Corporation, where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in medical therapies, particularly for viral infections.
Collaborations
Katou collaborates with notable colleagues, including Hiroshi Kawabata and Ryoma Miyake. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Ryouhei Katou's contributions to the development of hydrolase proteins represent a significant step forward in biochemistry and therapeutic applications. His innovative work continues to inspire advancements in the synthesis of important medical agents.